Literature DB >> 24594080

A one step real time PCR method for the quantification of hepatitis delta virus RNA using an external armored RNA standard and intrinsic internal control.

Ersin Karataylı1, Yasemin Çelik Altunoğlu1, Senem Ceren Karataylı1, S Gökçe K Alagöz1, Kubilay Cınar2, Kendal Yalçın3, Ramazan Idilman2, Cihan Yurdaydın4, A Mithat Bozdayı5.   

Abstract

BACKGROUND: Hepatitis delta virus (HDV) RNA viral load measurement is critical in diagnosis and monitoring the response to antiviral treatment.
OBJECTIVES: Our aim is to design a real time PCR method for accurate quantitation of HDV RNA in clinical specimens using an armored RNA as external standard, and an intrinsic internal control. STUDY
DESIGN: A plasmid bearing delta antigen region of genotype I HDV genome was used to develop an armored RNA. Serial dilutions of the armored HDV RNA standard with 10(12)copy/mL were used as standards for quantitation. A primer-probe set derived from HDAg region was used in one step EZ RT PCR kit chemistry which uses rTth enzyme allowing reverse transcription and polymerization in the same tube. The kit also uses the advantage of uracil-N-glycosylase (UNG) enzyme treatment to prevent PCR contamination.
RESULTS: The established assay has a dynamic range of 10(2)-10(11)copy/mL with a PCR efficiency of 96.9%. Detection limit was 858±32copy/mL with 95% confidence interval. Intra- and inter-assay variabilities were low for high, medium and low levels of viremia. Incorporation of freely circulating GAPDH in serum into the assay as an intrinsic internal control prevented false negative results and failures in PCR amplifications due to inhibitors, inefficient extraction procedures or enzymatic reactions.
CONCLUSION: In conclusion, this study defines a novel assay for sensitive and reliable quantification of HDV RNA using an armored HDV RNA as a standard and GAPDH in plasma or serum as an intrinsic internal control in a single tube.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Armored RNA; HDV; Intrinsic control; Real time PCR

Mesh:

Substances:

Year:  2014        PMID: 24594080     DOI: 10.1016/j.jcv.2014.01.021

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  5 in total

1.  Evaluation of the results of MOTAKK hepatitis C virus RNA genotyping and hepatitis delta virus external quality assessment programs during 2015-2016.

Authors:  Ersin Karataylı; Ege Soydemir; Zeynep Büşra Aksoy; Mehtap Kızılpınar; Aylin Altay Koçak; Senem Ceren Karataylı; Esra Yurdcu; Umut Yıldırım; Haluk Güriz; Gülendam Bozdayı; Cihan Yurdaydın; Osman İlhan; Yasin Yıldırım; Motakk Hcv Genotype And Hdv Study Group; A Mithat Bozdayı
Journal:  Turk J Gastroenterol       Date:  2019-11       Impact factor: 1.852

2.  Optimization and validation of a real-time polymerase chain reaction protocol for the diagnosis of human brucellosis.

Authors:  Hasan Zeybek; Ziya Cibali Acikgoz; Tuba Dal; Rıza Durmaz
Journal:  Folia Microbiol (Praha)       Date:  2019-07-31       Impact factor: 2.099

3.  A novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus-infected mongolians.

Authors:  Xiaohua Chen; Odgerel Oidovsambuu; Ping Liu; Rosslyn Grosely; Menashe Elazar; Virginia D Winn; Benjamin Fram; Zhang Boa; Hongjie Dai; Bekhbold Dashtseren; Dahgwahdorj Yagaanbuyant; Zulkhuu Genden; Naranbaatar Dashdorj; Andreas Bungert; Naranjargal Dashdorj; Jeffrey S Glenn
Journal:  Hepatology       Date:  2017-10-30       Impact factor: 17.425

4.  Development and Evaluation of a Novel Armored RNA Technology Using Bacteriophage Qβ.

Authors:  Lin Yao; Fengling Li; Meng Qu; Yingying Guo; Yanhua Jiang; Lianzhu Wang; Yuxiu Zhai
Journal:  Food Environ Virol       Date:  2019-08-21       Impact factor: 2.778

5.  Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan.

Authors:  Abbas Ali Husseini; Khwaja Mir Islam Saeed; Esra Yurdcu; A Mithat Bozdayı
Journal:  Turk J Gastroenterol       Date:  2020-09       Impact factor: 1.852

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.